More than 8 million people in the U.S. take blood thinners, also called anticoagulants. Many are prescribed the drugs after ...

DEAR DR. ROACH: I’m 83 and was recently diagnosed with atrial fibrillation. My doctor put me on Eliquis. I have had no problems with it, except the cost. Is there something comparable that is less ...

Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints--a composite of ...

For patients with atrial fibrillation, the risk of stroke or heart attack from stopping anticoagulants usually outweighs the risk of bleeding, according to new findings from the University of Bath.

Andexxa is a recombinant modified human factor Xa protein that received accelerated approval in 2018 for reversal of anticoagulation with rivaroxaban or apixaban due to life-threatening or ...

The BMS-Pfizer alliance has dominated the anticoagulant drug market, earning approximately $82.6bn in revenue since 2011.

Apixaban (Eliquis) was associated with lower serious bleeding rates than rivaroxaban (Xarelto) or warfarin in patients with cirrhosis and atrial fibrillation (AF, Afib) in a nationwide cohort study.